The Establishment noted that the product was not imported through the official channels approved by the Establishment.

EDE warned that the use of such counterfeit products may pose a serious risk to public health, as they do not comply with approved specifications and could result in harmful health reactions or unforeseen complications.

The Emirates Drug Establishment called on healthcare providers, pharmacies and medical facilities to carefully verify the authenticity of medical products before using or dispensing them, and to immediately cease the use, distribution or circulation of any units carrying the specified batch number.

EDE also advised patients to consult a physician or pharmacist if they experience any unusual symptoms following use, and emphasised the importance of reporting any suspected products or irregular activities related to the distribution or handling of this batch.